Sign up to save your podcasts
Or
Share Little Pharma On The Rise
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Little Pharma On The Rise
Concert Pharmaceuticals’ stock rises 80% on a deal with Vertex. Jason Moser analyzes the pharmaceutical landscape and weighs in on The New York Times’ new Twitter strategy. Plus we dip into the Fool Mailbag and share memories of the late Paul Kangas.
View all episodes
By The Motley Fool
4.7
16041,604 ratings
Concert Pharmaceuticals’ stock rises 80% on a deal with Vertex. Jason Moser analyzes the pharmaceutical landscape and weighs in on The New York Times’ new Twitter strategy. Plus we dip into the Fool Mailbag and share memories of the late Paul Kangas.
More shows like MarketFoolery
View all
Motley Fool Hidden Gems Investing
3,216 Listeners
InvestTalk
1,489 Listeners
Motley Fool Answers
807 Listeners
Rule Breaker Investing
947 Listeners
Investing Insights
523 Listeners
Bloomberg Surveillance
1,166 Listeners
Masters in Business
2,182 Listeners
Industry Focus
825 Listeners
The Investing for Beginners Podcast - Your Path to Financial Freedom
1,421 Listeners
Wall Street Breakfast
1,037 Listeners
The Best One Yet
9,718 Listeners
Chit Chat Stocks
196 Listeners
Ready For Retirement
827 Listeners
The Canadian Investor
87 Listeners
Early Retirement - Financial Freedom (Investing, Tax Planning, Retirement Strategy, Personal Finance)
587 Listeners
The Morgan Housel Podcast
1,033 Listeners
Stock Market Today With IBD
53 Listeners